Perpetua Medical AB (publ) OMXSTO:PERP_B:
SUBSIDIARY SPIROTRONIC RECEIVES SIGNIFICANT ORDER FROM LEADING MEDTECH COMPANY
ORDER COULD GENERATE 6 MILLION SEK CONSULTING REVENUES IN 2026
Perpetua Medical's Subsidiary Gets Significant Order
Earlier from Perpetua Medical Ab Class B
- PERP_B: Q2 2025 sales up 165%, losses reduced, major acquisition and asset sale boost outlook
- PERP_B: Strong sales growth from ES-Medical offset by negative operating result and strategic realignment
- PERP_B: Q4 revenue jumped 62% on ES-Medical, with improved losses and strong cash flow
- PERP_B: First acquisition completed, losses reduced, and cost base lowered as strategic shift advances